Status:
COMPLETED
Efficacy of Nifedipine Versus Hydralazine in Management of Severe Hypertension in Pregnancy
Lead Sponsor:
Adebayo Joshua Adeniyi
Conditions:
Hypertension
Eligibility:
FEMALE
18-49 years
Phase:
NA
Brief Summary
Introduction - Hypertension is the commonest medical complication of pregnancy. When severe, it puts the lives of both the mother and the unborn baby at risk. Therefore, immediate lowering of blood pr...
Detailed Description
Introduction Hypertension is the commonest medical complication of pregnancy. It is associated with high maternal and perinatal mortality, especially when severe. Hypertensive disorders of pregnancy c...
Eligibility Criteria
Inclusion
- Women with singleton pregnancy
- Gestational age of 28 weeks and above
- Severe hypertension in pregnancy
Exclusion
- Patients who do not consent to the study
- Unconscious patients
- Complications of hypertension in pregnancy such as cerebrovascular accident, severe renal impairment and heart disease
- Multiple gestation
- Gestational ages below 28 weeks
Key Trial Info
Start Date :
August 13 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 20 2019
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT04435210
Start Date
August 13 2018
End Date
February 20 2019
Last Update
June 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alex Ekwueme Federal University Teaching Hospital
Abakaliki, Ebonyi State, Nigeria, 840001